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The  aim  of  this  study  was  to  seek  possible  links between  the  regionality  along  the  digestive  tract  and
the  accumulation  of  reactive  oxygen  species,  the  effectiveness  of  the  antioxidant  defense  system  and  the
sensitivity  to  the  types  of  demise  in  different  gut  regions  of rats  with  streptozotocin-induced  diabetes.
Signiﬁcant  changes  were  observed  in  the oxidative  status  and  in  the  activity  of the  antioxidant  defense
system  in  the  diabetic  colon;  the  peroxynitrite  production  was doubled,  the level  of  hemoxygenase-
2  protein  was increased  11-fold  and  the  expression  of  anti-apoptotic  bcl-2  was also  increased.  The
segment-speciﬁc  vulnerability  of  the  gastrointestinal  tract  induced  by  hyperglycemia  was  also  conﬁrmed
by  electron  microscopy,  demonstrating  the  presence  of  severe  necrosis  in  the  colon  of the diabetic  rats.  Noigestive tract
eroxynitrite
ecrosis
remarkable  histopathological  alterations  were  seen  in the duodenum  of the  diabetic  animals  and  there
were likewise  no  signiﬁcant  changes  in  the  production  of  peroxynitrite  in  their duodenum,  whereas  the
level  of  the free radical  scavenger  metallothionein-2  was increased  ∼300-fold.
Conclusion:  The  spatially  restricted  vulnerability  observed  along  the  digestive  tract  could  originate  from
a high  level  of  oxidative  stress  via  peroxynitrite  production.
©  2015  Elsevier  Ltd. All  rights  reserved.. Introduction
Type 1 diabetes mellitus (T1D) results in severe metabolic
mbalances and pathological changes in many tissues, and com-
only affects the entire gastrointestinal (GI) tract, from the
sophagus to the anorectal region (Wolosin and Edelman, 2000;
hao et al., 2002). T1D involves a state of high oxidative stress
enerated as a result of hyperglycemia-induced reactive oxy-
en species (ROS) (Wolff, 1993). Oxidative stress is an imbalance
etween the production of ROS, and the ability of a biological sys-
em to achieve the ready detoxiﬁcation of ROS or to repair the
esulting damage. While ROS are important second messengers
t low concentrations and are involved in the regulation of apo-
tosis and the activation of transcription factors, they can cause
igniﬁcant cellular damage when present in excess. They can inﬂict
amage on all classes of cellular macromolecular components,
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357-2725/© 2015 Elsevier Ltd. All rights reserved.eventually leading to tissue injury or even cell death, which
can occur essentially by two  mechanisms, necrosis and apopto-
sis (Bergamini et al., 2004). Although numerous reports have
provided details of the molecular mechanisms responsible for ROS-
induced apoptosis, little is known concerning the mechanisms and
signal transduction pathways underlying ROS-mediated necrotic
cell death. Necrosis has long been considered to be a passive
mode of cell death (Kanduc et al., 2002) and much more harmful
than apoptosis because it causes a robust inﬂammatory response
(Proskuryakov et al., 2003).
To eliminate the harmful effects of reactive species, cells are
equipped with an efﬁcient antioxidant defense system, including
enzymes such as superoxide dismutase (SOD), catalase (CAT), and
heme oxygenases (HOs), and low-molecular weight antioxidants
such as glutathione (GSH) and metallothioneins (MTs) (Kruidenier
et al., 2003; Inoue et al., 2008). SOD catalyzes the reduction of
the superoxide anion (•O2−) to hydrogen peroxide (H2O2), which
is then detoxiﬁed to water by CAT in the lysosomes (Wang and
Ballatori, 1998). The HOs play roles in heme degradation, yield-
ing equimolar amounts of biliverdin, and carbon monoxide with
important free radical-scavenging properties and free iron. HO-2 is
expressed constitutively, contributing to cell homeostasis, whereas
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O-1 is an inducible enzyme expressed at a relatively low level in
ost tissues (Maines, 1997), recently identiﬁed as an important cel-
ular defense mechanism against oxidative stress (Abraham et al.,
009). HO-1 and HO-2 are regulated by strikingly different mech-
nisms, which may  reﬂect different physiological and pathological
oles (Gibbons and Farrugia, 2004).
GSH also plays a critical role in this system, as an antioxi-
ant, enzyme cofactor and major redox buffer (Wang and Ballatori,
998). The MTs  are present in all cells throughout the body. They
ave a cardinal role in metal homeostasis and heavy metal detox-
ﬁcation through their high metal-binding capacity, they play a
ole in the immune function, and they are involved in a variety
f GI tract functions (Thirumoorthy et al., 2011). They also play an
mportant part in the prevention of development of T1D, the com-
lications and the subsequent pathogenic toxicity (Cai, 2004). The
verexpression of MTs  in various metabolic organs has been shown
o reduce hyperglycemia-induced oxidative stress, organ-speciﬁc
iabetic complications, and DNA damage in experimental diabetes
Islam and Loots, 2007).
In an earlier study, we demonstrated spatially-restricted dam-
ge of the gut capillary endothelium in rats with streptozotocin
STZ)-induced diabetes in comparison with control animals (Bódi
t al., 2012). Metagenomic analysis of the luminal contents of duo-
enum, ileum and colon of diabetic rats also furnishes evidence
f the regionality of the gut microbiota (Wirth et al., 2014). The
wo studies are in good agreement as concerns the advantageous
tatus of the duodenum of the diabetic rat as compared with the
olon.
Those results led us to focus in the present study on the spatially-
estricted differences in ROS production and activation of the
ntioxidant defense system in the duodenum and colon of rats with
TZ-induced diabetes. The aim of the study was to characterize
he possible links between the antioxidant status and the macro-
olecular damage in selected gut segments in the diabetic rat. We
eport data on the accumulation of a powerful oxidant, peroxyni-
rite (ONOO−), the activities of antioxidant enzymes (SOD and CAT),
nd the expressions of a set of genes coding for members of antiox-
dant defense system (mt-1, mt-2, ho-1 and ho-2), together with the
etection of pro-apoptotic and anti-apoptotic markers (bax, bcl-2
nd caspase-9).
. Materials and methods
.1. Animal model
Adult male Wistar rats weighing 300–400 g, kept on standard
aboratory chow (Bioplan Kft., Hungary) and with free access to
rinking water, were used throughout the experiments. The rats
ere divided randomly into three groups: STZ-induced diabetics
n = 14), insulin-treated diabetics (n = 12) and sex- and age-matched
ontrols (n = 6).
Hyperglycemia was induced as described previously (Izbéki
t al., 2008). The animals were considered diabetic if the non-
asting blood glucose concentration was higher than 18 mM.  From
his time on, one group of hyperglycemic rats received a subcuta-
eous injection of insulin (Humulin M3,  Eli Lilly Nederland) each
orning (4 U) and afternoon (2 U). The non-fasting blood glucose
oncentration and weight of each animal were measured weekly.
he cecum size of the sacriﬁced rat was analyzed by means of the
mage J 1.48v program (http://imagej.nih.gov/ij/). In all procedures
nvolving experimental animals, the principles of laboratory animal
are (NIH publication no. 85-23, revised 1985) were followed and
ll the experiments received approval in advance from the Local
thics Committee for Animal Research Studies at the University of
zeged.emistry & Cell Biology 62 (2015) 125–131
2.2. Tissue handling
Ten weeks after the onset of diabetes, the animals were killed by
cervical dislocation under chloral hydrate anesthesia (375 mg/kg
i.p.). The gut segments of the control, STZ-induced diabetic and
insulin-treated diabetic rats were dissected and rinsed in 0.05 M
phosphate buffer, pH 7.4. Samples were taken from the duode-
num (1 cm distal to the pylorus) and the middle part of the colon
and processed for biochemical, molecular biological and electron
microscopy study.
2.3. Biochemical assays
0.5 g duodenum and colon of each individual rats, tissues were
homogenized in 4 volume of ice-cold 0.9% serum physiologic by
means of a glass homogenizer immersed in an ice water bath, cen-
trifuged at 17,000 × g for 15 min  at 4 ◦C, and the clear supernatants
used for GSH, ONOO−, protein analysis, and measuring the activities
of antioxidant enzymes.
Total protein levels measured by the method of Lowry et al.
(1951) using bovine serum albumin as a standard. The concen-
trations of total and reduced GSH in the tissues were measured
as described by Sedlak and Lindsay (1968). Spectrophotometric
measurements were carried out by GENESYS 10S UV-Vis (Thermo
Scientiﬁc) spectrophotometer.
ONOO− was assayed by diluting samples into 1 M NaOH (60:1)
and measuring the increase in absorbance at 302 nm.  As a con-
trol, samples were added to 100 mM potassium phosphate (pH 7.4)
(60:1). The decrease in absorbance was measured at neutral pH as
ONOO− decomposes (Huie and Padmaja, 1993).
Catalase activity was determined spectrophotometrically at
240 nm by the method of Beers and Sizer (1953) and expressed in
Bergmeyer units (1 BU = decomposition of 1 g H2O2/min at 25 ◦C).
SOD activity was determined on the basis of the inhibition
of epinephrine–adrenochrome autoxidation (Misra and Fridovich,
1972). Spectrophotometric measurement was carried out at
480 nm.  The results were expressed in U/mg protein.
2.4. Post-embedding immunohistochemistry
For post-embedding immuno-electromicroscopy, small pieces
(2–3 mm)  of the gut segments were ﬁxed overnight at 4 ◦C in 2%
paraformaldehyde and 2% glutaraldehyde solution, buffered with
0.1 M PB (pH 7.4). The samples were then washed in 0.05 M PB
and further ﬁxed for 1 h in 1% OsO4. After ﬁxation, the gut seg-
ments were rinsed in 0.1 M PB, dehydrated in increasing alcohol
concentrations (50, 70, 96% and absolute ethanol) and acetone,
and embedded in Epon (Electron Microscopy Sciences, Hatﬁeld, PA,
USA). The Epon blocks were used to prepare ultrathin (70 nm)  sec-
tions, which were mounted on Formvar-coated nickel grids and
processed for immunogold labeling.
Ultrathin sections from each block were pre-incubated in
1% bovine serum albumin in TRIS-buffered saline (TBS) for
30 min, incubated overnight in the primary antibodies (heme
oxygenase-2 mouse monoclonal IgG (Santa Cruz Biotechnology,
USA; working dilution 1:50) and caspase-9 rabbit polyclonal IgG
(Sigma–Aldrich, USA; working dilution 1:50)), followed by pro-
tein A-gold-conjugated anti-mouse (18 nm gold particles, Jackson
ImmunoResearch, West Grove, PA, USA; ﬁnal dilution 1:20) sec-
ondary antibodies for 3 h, with extensive washing in between. All
steps were performed at room temperature. The speciﬁcity of the
immunoreaction was assessed in all cases by omitting the primary
antibodies from the labeling protocol and incubating the sections
only in the protein A-gold-conjugated secondary antibodies. Sec-
tions were counterstained with uranyl acetate (Merck, Darmstadt,
Germany) and lead citrate (Merck, Darmstadt, Germany), and were
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xamined and photographed with a Philips CM 10 electron micro-
cope equipped with a MEGAVIEW II camera. The quantitative
roperties of gold particles coding for HO-2 and caspase-9 were
etermined in the myenteric ganglia and in the endothelium of
apillaries in the vicinity of these ganglia in all experimental group.
ounting was performed on digital photographs of ﬁve ganglia,
nd the entire endothelial proﬁle of ﬁve well-oriented capillaries,
hich were cut perpendicularly to their long axis and visualized
t a magniﬁcation of 5800×, per intestinal segment per condition
t a magniﬁcation of 34,000× with the AnalySIS 3.2 program (Soft
maging System GmbH, Münster, Germany). The intensity of the
abeling was expressed as the total number of gold particles per
nit area.
.5. RNA extraction, reverse transcription and PCR ampliﬁcation
Intestinal samples were homogenized in RNA Bee reagent (Tel-
est Inc., Friendswood, TX, USA) and total RNA was prepared
ccording to the procedure suggested by the manufacturer. Total
NA was routinely treated with 100 U RNAse-free DNAseI (Thermo
cientiﬁc) to avoid any DNA contamination. For assessing RNA con-
entration and purity the absorbance of a diluted RNA samples were
easured at 260 and 280 nm using NanoDrop 1000 UV/VIS Spec-
rophotometer (Thermo Scientiﬁc). The RNA concentration was
alculated using the A260 = 1.0 is equivalent to ∼40 g/ml single-
tranded RNA equation. The A260/A280 ratio was used to assess RNA
urity and ratio ∼2 was accepted for puriﬁed RNA.
First-strand cDNA was synthesized by using 3 g total RNA
s template, 200 pmol of each dNTP (Thermo Scientiﬁc), 200 U
axima H Minus Reverse Transcriptase (Thermo Scientiﬁc) and
00 pmol random hexamer primers (Sigma) in a ﬁnal volume of
0 L, and incubated for 10 min  at 37 ◦C, followed by 1 h at 52 ◦C.
eal-time qPCR was done for gene expression studies, using Lumi-
aris Color HiGreen Low ROX qPCR Master Mix  (Thermo Scientiﬁc)
n Applied Biosystems 7500 Real-Time PCR System (Life Tech-
ologies). The qPCR reactions were performed with a temperature
rogram of 10 min  at 95 ◦C (initial denaturing), followed by 40
ycles of 15 s at 95 ◦C; 1 min  at the annealing temperature 63 ◦C fol-
owed by a melting curve stage with temperature ramping from 60
o 95 ◦C and a ﬁnal cooling for 30 s at 40 ◦C. The quantities of exam-
ned mRNAs were normalized to that of ˇ-actin, a housekeeping
ene, and gene expression was calculated in terms of ddCt method
Livak and Schmittgen, 2001).
able 1
rimer sequences with accession number.
Gene Primers (5′ → 3′)
ho-1 (NM 012580)
GCTGCTGGTGGCCCACGCTT
ACAGTCCAATGTTGAGCAGG
ho-2 (NM 024387)
GCTGCTGGTGGCCCACGCTT
AGGGTTTCTTTTGTTAGCATGGA
mt-1 (M11794)
ATGGACCCCAACTGCTCCTG
TGGAGGTGTACGGCAAGACT
mt-2 (AY341880)
ATGGACCCCAACTGCTCCTG
GAAAAAAGTGTGGAGAACCG
Caspase-9 (NM 031632)
AGCCAGATGCTGTCCCATAC
CAGGAACCGCTCTTCTTGTC
bax (RRU49729)
GGAGGCGGCGGGCCCACCAG
CACGTCAGCAATCATCCTCTGC
bcl-2 (NM 016993)
GGAAGGATGGCGCAAGCCGG
CGCAGGCCCAGCGTTGGCGAC
ˇ-Actin (M24113)
GCAAGAGAGGTATCCTGACC
CCCTCGTAGATGGGCACAGTemistry & Cell Biology 62 (2015) 125–131 127
For the ampliﬁcation of rat mRNAs, isoform-speciﬁc primers
were designed on the basis of the data bank entries. For nor-
malization of the amounts of mt,  ho,  caspase-9,  bax and bcl-2
mRNAs, the ˇ-actin mRNA level was used as internal standard
(Table 1).
2.6. Statistical analysis
RT-qPCR reactions for each animal were performed in triplicate
to increase the reliability of the measurements. Statistical analysis
was performed with one-way ANOVA and the Newman–Keuls test.
All analyses were carried out with GraphPad Prism 4.0 (GraphPad
Software, La Jolla, CA, USA) and MedCalc Statistical Software ver-
sion 9.4.2.0 (MedCalc Software, Mariakerke, Belgium). A probability
level of p < 0.05 was  set as the level of statistical signiﬁcance. All data
were expressed as means ± SD.
3. Results
3.1. Ischemic and inﬂammatory hallmarks and peroxynitrite level
in different gut segments 10 weeks after the onset of diabetes
Rats were sacriﬁced and signs of intestinal inﬂammation and
severe ischemia (bluish-purple intestines and an enlarged cecum
(1.5–2-fold)) were observed in the diabetic animals as compared
with the controls (Fig. 1A and B). Intestinal ischemia was also visible
in the insulin-treated rats, but, the cecum was not enlarged (not
shown).
Ten weeks after the onset of diabetes there was  no signiﬁcant
change in ONOO− level in the duodenum in any of the examined
groups. However, the ONOO− level in the colon was  signiﬁcantly
increased (1.7–2-fold) in the diabetic rats, whereas in the insulin-
treated diabetic animals it was similar to the control level (Fig. 1C).
3.2. Activation of the antioxidant defense system
The GSH level in the duodenum was  elevated 2.5–3-fold in the
diabetic rats and 1.5-fold in the insulin-treated diabetic rats relative
to the control group (Fig. 2A). The elevation in the ratio GSH/GSSG
was even higher in this intestinal segment: a 6-fold increase was
measured in the diabetic animals (data not shown). In the colon,
the GSH and GSSG contents were not signiﬁcantly changed in any
of the experimental groups.
The SOD activity was unaltered in the duodenum, regardless
of the treatment, while it was  signiﬁcantly decreased in the colon
in the diabetic groups (Fig. 2B). The activity of CAT was not
signiﬁcantly affected by either the STZ-induced diabetes or the
insulin replacement in any of the intestinal segments examined
(Fig. 2C).
Ten weeks after the STZ injection, there was a 4-fold increase in
the expression of the ho-1 gene in the duodenum, but no signiﬁcant
change in the colon. Immediate insulin replacement maintained the
mRNA level close to the control value in both intestinal segments
(Table 2).
The expression of the mt-1 gene was  upregulated in both of the
examined gut segments of the diabetic animals: the mt-1 mRNA
level was  increased by 6- and 7-fold in the duodenum and the colon,
respectively. However, no signiﬁcant change in mt-1 expression
was observed in these intestinal segments in the insulin-treated
diabetic animals. The mt-2 mRNA content was  more than 300-fold
the control level in the duodenum of the diabetic animals, while
insulin treatment kept the expression level close to the control.
The expression of mt-2 did not change in the colon in the diabetic
and insulin-treated animals (Table 2).
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Fig. 1. Inﬂammatory hallmarks of gastrointestinal system (A, B) and accumulation of peroxynitrite (ONOO−) in different gut segments (C). Representative image of the freshly
dissected intestine of rats from control (A) and diabetic (B) animals. Bluish-purple intestinal color and enlarged cecum was  observed in diabetic animals. Data are expressed
as  means ± S.D. *p < 0.05 (relative to controls). C: control, n = 6; D: diabetics, n = 14; ID: insulin-treated diabetics, n = 12.
Fig. 2. Concentration of the antioxidant glutathione (GSH) (A), activities of superoxide d
groups.  Data are expressed as means ± S.D. *p < 0.05 (relative to controls). C: control, n = 6
Table 2
Fold of induction of the ho-1, mt-1 and mt-2 genes in the duodenum and colon of
rats with STZ-induced diabetes.
ho-1 mt-1 mt-2
Duodenum
C 1 1 1
D  3.93 ± 1.49*** 5.94 ± 2.32*** 324.74 ± 167.21*
ID 1.28 ± 0.06‡ 1.41 ± 0.51# 1.06 ± 0.01†
Colon
C 1 1 1
D  0.93 ± 0.06 7.5 ± 4.95* 1.4 ± 0.02
ID 0.74 ± 0.19 1.5 ± 0.99† 1.08 ± 0.01
Data are means ± S.D.
Analysis of variance (ANOVA):
* p < 0.05 (relative to controls).
*** p < 0.001 (relative to controls).
† p < 0.05 (relative to diabetic animals).
‡ p < 0.01 (relative to diabetic animals).
# p < 0.001 (relative to diabetic animals).ismutase (SOD) (B) and catalase (C) in different gut segments in all experimental
; D: diabetics, n = 14; ID: insulin-treated diabetics, n = 12.
3.3. Measurement of HO-2 expression in different gut segments
The expression of the ho-2 gene was upregulated signiﬁcantly
only in the colon in the diabetic and the insulin-treated diabetic
rats (Fig. 3A). The presence of HO-2 protein was  followed by
post-embedding immunohistochemistry. A ∼4-fold increase was
measured in the number of gold particles signing HO-2 in the
duodenum of the diabetic animals relative to the controls. In the
diabetic colon, there was a marked 11-fold elevation in the HO-2
labels resulting in a ∼5-fold higher protein level of HO-2 in the colon
versus duodenum. In both examined regions of the insulin-treated
diabetic rats the control level of HO-2 expression was observed
(Fig. 3B).
3.4. Effects of diabetes on apoptotic markers in the duodenum
and colonWe  examined the levels of the pro-apoptotic marker bax and the
anti-apoptotic marker bcl-2. In the duodenum of the diabetic rat, a
40% increase was  detected in the level of bax mRNA as compared
Z. Jancsó et al. / The International Journal of Biochemistry & Cell Biology 62 (2015) 125–131 129
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old  of induction. mRNAs are normalized to that of ˇ-actin. Quantitative evaluation
re  presented as means ± S.D. **p < 0.01, ***p < 0.001 (relative to controls). C: contro
ith the control and insulin-treated groups. However, in the colon
f the diabetic rats, the expression of the bax gene was  downregu-
ated by 15–20% (data not shown). The diabetes-induced alterations
n the expression of the anti-apoptotic marker blc-2 were the oppo-
ite of those in bax expression; no change or a non-signiﬁcant
ecrease in the duodenum, and a 40–45% increase in the colon. As
 consequence, the ratio bax/bcl-2 differed even more dramatically
n the two intestinal segments: a 50% increase in the duodenum,
nd a 40% decrease in the colon (Fig. 4A).
The expression pattern of caspase-9 in the duodenum was  simi-
ar to that of bax.  There was a signiﬁcant 2.5–3-fold increase in the
aspase-9 mRNA level in the diabetic rats. The expression pattern
f this gene was unchanged in the colon in the diabetic animals and
he level was the same as the control in the animals treated with
nsulin (Fig. 4B). The intestinal caspase-9 protein expression was
lso demonstrated by immunohistochemistry. The number of gold
articles labeling caspase-9 was signiﬁcantly higher in the duode-
um of diabetic rats than the control (Fig. 4C and D), while the
umber of labels in the colon was unchanged.
The segment-speciﬁc vulnerability of the gastrointestinal tract
nduced by hyperglycemia was also conﬁrmed by electron
icroscopy, demonstrating the presence of severe necrosis in
he colon of the diabetic rats. The hyperglycemic colon samples
requently exhibited necrotic smooth muscle cells with a barely
ecognizable cytoplasm, and the structural integrity of the plasma
embrane was lost (Fig. 5).
. Discussion
This study has presented data on gut segment speciﬁc oxidative
tress, the effectiveness of the antioxidant defense system and the
issue damage in the duodenum and colon in rats with diabetes.
The segment-speciﬁc vulnerability of the GI tract was  conﬁrmed
y RT-qPCR, immunohistochemistry and electron microscopy (EM).
M demonstrated the presence of severe necrosis in the colon of the
iabetic rats. Changes in ROS production, as presumptive candi-
ates triggering necrosis were also demonstrated in the colon: the
NOO− production was doubled. Elevated level of ONOO− serves
s indirect evidence of increased •O2− and NO production in the
olon. An increasing number of studies have implicated ONOO− in
he development of T1D-associated complications (Pacher et al.,
007). A study of the pathogenesis of inﬂammatory bowel disease
ielded evidence that intrarectally administered ONOO− inducedene (A) in different gut segments in all experimental groups. Data are expressed as
 number of gold particles labeling HO-2 in the duodenum and colon (B). All values
; D: diabetics, n = 14; ID: insulin-treated diabetics, n = 12.
inﬂammation and transmucosal necrosis in the rat colon
(Rachmilewitz et al., 1993). The activity of SOD in the diabetic colon
was signiﬁcantly reduced, which status also could be a consequence
of the fast depletion of •O2− through its reaction with NO, which
is 3 times faster than the SOD-catalyzed reduction of •O2− (Walsh,
1997).
Or study has also demonstrated that the intestine possesses sev-
eral defense mechanisms in a segment-speciﬁc manner: maintains
high concentrations of the antioxidant GSH and upregulates the
expressions of hos  and mts so as to preserve cellular integrity.
GSH is present in high concentrations in the tissues and par-
ticipates in the cellular defense by scavenging ROS (Nicotera and
Orrenius, 1986; Flechner et al., 1990). Our study has revealed a
marked increase in GSH level in the duodenal tissues, but not in
the colon, in diabetic rats. High GSH levels protect cellular proteins
against oxidation through the GSH redox cycle, and also directly
detoxify ROS induced by exposure to STZ (Raza et al., 2000).
Besides the GSH system, the MTs  also play a noteworthy role
in the maintenance of the physiological thiol/redox balance. The
MTs  may  serve as potent antioxidants preventing diabetic com-
plications through the suppression of diabetic oxidative damage
(Dabrowiak, 2009). Our study revealed the accumulation of a huge
amount of mt-2 mRNA in the diabetic duodenum. The expression of
mt-1 was induced to about the same level in the diabetic duodenum
and colon. In the colon, this 7-fold elevation in mt-1 mRNA level
is one of the few positive signs of an active antioxidant defense.
It has been documented that Zn-induced mt  synthesis in rat pan-
creas prevented STZ-induced diabetes (Yang and Cherian, 1994).
Elevated levels of MTs  in the liver and kidney of diabetic rats have
also been reported (Craft and Failla, 1983; Failla and Kiser, 1981;
Uriu Hare et al., 1988), and overexpressed mt in the mouse heart
signiﬁcantly prevented diabetes-induced cardiomyopathy (Cai and
Kang, 2001; Kang and Cai, 2001).
We also demonstrated gut segment-speciﬁc changes in the
expression of the HOs during diabetes. A number of in vivo and
in vitro studies have indicated the induction of the HO system
in response to a wide array of oxidative and cellular stresses
(Applegate et al., 1991; Nath, 1994; Vile et al., 1994; Otterbein et al.,
1995). HO-1 and HO-2 share similar physical and kinetic proper-
ties, but have different physiological roles and tissue distributions
(Maines, 2005). In our system, hyperglycemia induced ho-1 expres-
sion in the duodenum, while in the colon increased amounts of ho-2
mRNA and HO-2 protein were detected. Unlike HO-1, which lacks
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Fig. 4. Expressions of apoptotic markers in the duodenum and colon. Ratio bax/bcl-2 (A) and expression of caspase-9 gene (B) in different gut segments of control (C) n = 6,
diabetic  (D) n = 14 and insulin-treated diabetic (ID) n = 12 rats. Data are expressed as fold of induction. Representative electron micrograph of ultrathin section of the enteric
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mmooth  muscle cells (smc) in the duodenum of diabetic rat after post-embedding i
he  18 nm gold particles (arrows) labeling caspase-9 accumulated above the mitoch
aspase-9 (D). All values are presented as means ± S.D. *p < 0.05, **p < 0.01, ***p < 0.0
ysteine residues, HO-2 contains three Cys-Pro signature motifs,
nown as heme regulatory motifs (HRMs). It has been proposed
Ragsdale and Yi, 2011) that the HRMs act as a “molecular rheo-
tat” that responds to the intracellular redox potential, controlling
he HO-2 activity. The level of HO-2 protein increased 11-fold, and
he activity could be further enhanced by free radicals via the Cys-
ro signature motifs. The release of Fe ion during heme degradation
efore their sequestration by ferritin may  make them available for
he catalysis of harmful oxidation reactions (Rouault, 2009).
HO overexpression results in an anti-apoptotic phenotype asso-
iated with an increased expression of bcl-2 in diabetic rats (Cao
t al., 2008). The survival function of bcl-2 depends on the extent
f binding to proteins such as Bax that seem to antagonize bcl-
 activity (Ashkenazi and Dixit, 1998; Kroemer, 1997). Our study
as presented evidence of the gut region-speciﬁc expression of
cl-2, bax and caspase-9 the key elements of apoptotic pathways
Thornberry and Lazebnik, 1998). In the duodenal tissues of the
iabetic rats, the level of bax expression was increased, resulting in
ajor changes in the ratio bax/bcl-2 mRNA. These changes, alongohistochemistry (C), using a caspase-9-speciﬁc primary antibody. The majority of
a (m). Bar: 500 nm.  Quantitative evaluation of the number of gold particles labeling
lative to controls).
with an increased level of caspase-9, an initiator caspase in the apo-
ptosis pathway, indicate an enhanced pro-apoptotic environment,
triggering the event of programmed cell death in the duodenum. In
the diabetic colon the ratio bax/bcl-2 is lowered as a consequence
of upregulation of the bcl-2 expression. The observed increase in
bcl-2 expression could possibly be attributed to the highly elevated
HO-2 level.
All of these data suggest that the colon is more vulnerable
than the duodenum to oxidative stress. The fact that the antioxi-
dant protection is more efﬁcient in the proximal intestinal sections
than in the distal sections may  be a consequence of the posi-
tional and functional differences (Blázovics et al., 2004). Earlier
ﬁndings supported this (Sanders et al., 2004): the colon generates
more endogenous ROS than does the small intestine, and this basic
pro-oxidant environment of the colon may  lead to its inability to
handle oxidative stress as effectively as the small intestine. A recent
study on intestinal bacterial populations in T1D likewise empha-
sized regionality along the GI tract; T1D affected the composition
of the microbiota in a gut region-speciﬁc manner: the composition
Z. Jancsó et al. / The International Journal of Bioch
F
u
m
o
p
e
a
C
R
A
A
A
B
B
B
B
C
C
C
C
M
F
F
Yang J, Cherian MG.  Protective effects of metallothionein on streptozotocin-inducedig. 5. Necrotic hallmark in diabetic rats. Representative electron micrograph of an
ltrathin section on the colon of a diabetic rat. Smooth muscle cell (smc) with local
embrane injuries and leaky cytoplasm (arrows) were frequently seen. Bar: 10 m.
f the duodenal microbiota did not indicate the development of a
athological enteric microenvironment. In the diabetic colon how-
ver, the increased level of the Gram-negative Klebsiella could be
ssociated with severe intestinal inﬂammation (Wirth et al., 2014).
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